PDB66 COSTS OF THE PHARMACEUTICAL PROGRAM TO TREAT T2DM PATIENTS FROM HIPERDIA- GOVERNMENT HEALTH CARE PROGRAM FOR DIABETES AND HYPERTENSION POPULATION UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.574
https://www.valueinhealthjournal.com/article/S1098-3015(11)00713-3/fulltext
Section Title :
Disease-Specific Studies
Section Order :
28
First Page :
A103
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00713-3&doi=10.1016/j.jval.2011.02.574